Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-06-26 01:44 |
PROSPECTUS SUPPLEMENT to Prospectus dated December 13, 2019
|
English | 611.4 KB | ||
| 2020-06-26 01:44 |
PROSPECTUS SUPPLEMENT to Prospectus dated December 13, 2019
|
English | 38.4 KB | ||
| 2020-06-24 01:32 |
Kitov Announces $35.0 Million Registered Direct Offering
|
English | 127.3 KB | ||
| 2020-06-24 01:32 |
Kitov Announces $35.0 Million Registered Direct Offering
|
English | 38.5 KB | ||
| 2020-05-24 00:45 |
Kitov Announces FDA Acceptance of IND Application to Conduct Phase 1/2 Clinical…
|
English | 109.0 KB | ||
| 2020-05-24 00:45 |
Kitov Announces FDA Acceptance of IND Application to Conduct Phase 1/2 Clinical…
|
English | 38.6 KB | ||
| 2020-05-20 17:32 |
6K:Kitov Announces U.S. Commercial Launch of Consensi™
|
English | 173.2 KB | ||
| 2020-05-20 17:32 |
6K:Kitov Announces U.S. Commercial Launch of Consensi™
|
English | 38.6 KB | ||
| 2020-05-20 16:49 |
PR: Kitov Announces U.S. Commercial Launch of Consensi™
|
English | 97.0 KB | ||
| 2020-05-20 16:49 |
PR: Kitov Announces U.S. Commercial Launch of Consensi™
|
English | 38.1 KB | ||
| 2020-05-20 01:44 |
FORM 6-K-Kitov to Present Preclinical Data on NT219 at American Association of …
|
English | 154.1 KB | ||
| 2020-05-20 01:44 |
FORM 6-K-Kitov to Present Preclinical Data on NT219 at American Association of …
|
English | 38.6 KB | ||
| 2020-05-19 17:16 |
Press Release: Kitov to Present Preclinical Data on NT219 at American Associati…
|
English | 52.5 KB | ||
| 2020-05-19 17:16 |
Press Release: Kitov to Present Preclinical Data on NT219 at American Associati…
|
English | 38.2 KB | ||
| 2020-05-19 02:24 |
FORM S-8-REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
|
English | 396.5 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
